Pharmacotherapeutic strategies for managing comorbid depression and diabetes

References

• GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1211–1259.
   Web of Science ®Google Scholar
• Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016 Apr 9;387(10027):1513–1530.
   PubMed Web of Science ®Google Scholar
• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016 May 27;118(11):1723–1735.
   PubMed Web of Science ®Google Scholar
• Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with Type 2 diabetes. N Engl J Med. 2015 Oct 29;373(18):1720–1732.
   PubMed Web of Science ®Google Scholar
• Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010 Jun 26;375(9733):2215–2222.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of disease study 2010. Lancet. 2012 Dec 15;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015 Jun;3(6):461–471.
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001 Jun;24(6):1069–1078.
   PubMed Web of Science ®Google Scholar
• Novak M, Mucsi I, Rhee CM, et al. Increased risk of incident chronic kidney disease, cardiovascular disease, and mortality in patients with diabetes with comorbid depression. Diabetes Care. 2016 Nov;39(11):1940–1947.
   PubMed Web of Science ®Google Scholar
• Schmitz N, Gariepy G, Smith KJ, et al. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care. 2014 Apr;37(4):970–978.
   PubMed Web of Science ®Google Scholar
• van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):380–395.
   PubMed Web of Science ®Google Scholar
• Perrin NE, Davies MJ, Robertson N, et al. The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2017 Nov;34(11):1508–1520.
   PubMed Web of Science ®Google Scholar
• Buchberger B, Huppertz H, Krabbe L, et al. Symptoms of depression and anxiety in youth with type 1 diabetes: A systematic review and meta-analysis. Psychoneuroendocrinology. 2016 Aug;70:70–84.
   PubMed Web of Science ®Google Scholar
• Ali S, Stone MA, Peters JL, et al. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006 Nov;23(11):1165–1173.
   PubMed Web of Science ®Google Scholar
• Hussain S, Habib A, Singh A, et al. Prevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis. Psychiatry Res. 2018 Sep 19;270:264–273.
   PubMed Web of Science ®Google Scholar
• Li C, Ford ES, Strine TW, et al. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008 Jan;31(1):105–107.
   PubMed Web of Science ®Google Scholar
• Salinero-Fort MA, Gomez-Campelo P, San Andres-Rebollo FJ, et al. Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study): results from the MADIABETES cohort. BMJ Open. 2018 Sep 24;8(9):e020768.
   PubMed Web of Science ®Google Scholar
• Castellano-Guerrero AM, Guerrero R, Relimpio F, et al. Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting. Acta Diabetol. 2018 Sep;55(9):943–953.
   PubMed Web of Science ®Google Scholar
• Sun JC, Xu M, Lu JL, et al. Associations of depression with impaired glucose regulation, newly diagnosed diabetes and previously diagnosed diabetes in Chinese adults. Diabet Med. 2015 Jul;32(7):935–943.
   PubMed Web of Science ®Google Scholar
• Yu S, Yang H, Guo X, et al. Prevalence of depression among rural residents with diabetes mellitus: a cross-sectional study from Northeast China. Int J Environ Res Public Health. 2016 May 28;13:6.
   Web of Science ®Google Scholar
• Sorkin DH, Ngo-Metzger Q, Billimek J, et al. Underdiagnosed and undertreated depression among racially/ethnically diverse patients with type 2 diabetes. Diabetes Care. 2011 Mar;34(3):598–600.
   PubMed Web of Science ®Google Scholar
• Twist K, Stahl D, Amiel SA, et al. Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med. 2013 Oct;75(8):791–797.
   PubMed Web of Science ®Google Scholar
• Petrak F, Baumeister H, Skinner TC, et al. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol. 2015 Jun;3(6):472–485.
   PubMed Web of Science ®Google Scholar
• Skinner TC, Carey ME, Cradock S, et al. Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial. Diabet Med. 2010 Aug;27(8):965–967.
   PubMed Web of Science ®Google Scholar
• Sullivan MD, O’Connor P, Feeney P, et al. Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care. 2012 Aug;35(8):1708–1715.
   PubMed Web of Science ®Google Scholar
• Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003 Oct;26(10):2822–2828.
   PubMed Web of Science ®Google Scholar
• Naicker K, Johnson JA, Skogen JC, et al. Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal Associations With Mortality Risk. Diabetes Care. 2017 Mar;40(3):352–358.
   PubMed Web of Science ®Google Scholar
• Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry. 2013 May-Jun;35(3):217–225.
   PubMed Web of Science ®Google Scholar
• Katon W, Pedersen HS, Ribe AR, et al. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry. 2015 Jun;72(6):612–619.
   PubMed Web of Science ®Google Scholar
• Sullivan MD, Katon WJ, Lovato LC, et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry. 2013 Oct;70(10):1041–1047.
   PubMed Web of Science ®Google Scholar
• Molosankwe I, Patel A, Jose Gagliardino J, et al. Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord. 2012 Oct;142(Suppl):S42–S55.
   PubMedGoogle Scholar
• Kimbro LB, Steers WN, Mangione CM, et al. The association of depression and the cardiovascular risk factors of blood pressure, HbA1c, and body mass index among patients with diabetes: results from the Translating Research into Action for diabetes study. Int J Endocrinol. 2012;2012:747460.
   PubMedGoogle Scholar
• Dipnall JF, Pasco JA, Meyer D, et al. The association between dietary patterns, diabetes and depression. J Affect Disord. 2015 Mar;15(174):215–224.
   Google Scholar
• Mendenhall E, Norris SA, Shidhaye R, et al. Depression and type 2 diabetes in low- and middle-income countries: a systematic review. Diabetes Res Clin Pract. 2014 Feb;103(2):276–285.
   PubMed Web of Science ®Google Scholar
• Demmer RT, Gelb S, Suglia SF, et al. Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus. Psychosom Med. 2015 May;77(4):467–477.
   PubMed Web of Science ®Google Scholar
• Nefs G, Pouwer F, Denollet J, et al. The course of depressive symptoms in primary care patients with type 2 diabetes: results from the diabetes, depression, Type D personality Zuidoost-Brabant (DiaDDZoB) study. Diabetologia. 2012 Mar;55(3):608–616.
   PubMed Web of Science ®Google Scholar
• Chen PC, Chan YT, Chen HF, et al. Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care. 2013 Feb;36(2):376–382.
   PubMed Web of Science ®Google Scholar
• Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. Jama. 2008 Jun 18;299(23):2751–2759.
   PubMed Web of Science ®Google Scholar
• Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011 Feb-Mar;73(2):114–126.
   PubMed Web of Science ®Google Scholar
• Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004 Jan 1;55(1):1–9.
   PubMed Web of Science ®Google Scholar
• Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006 May;49(5):837–845.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar 1;67(5):446–457.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008 Jan;9(1):46–56.
   PubMed Web of Science ®Google Scholar
• Lunghi C, Zongo A, Moisan J, et al. The impact of incident depression on medication adherence in patients with type 2 diabetes. Diabetes Metab. 2017 Dec;43(6):521–528.
   PubMed Web of Science ®Google Scholar
• Whitworth SR, Bruce DG, Starkstein SE, et al. Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: the Fremantle Diabetes Study Phase II. Diabetes Res Clin Pract. 2016 Dec;122:190–197.
   PubMed Web of Science ®Google Scholar
• Campayo A, de Jonge P, Roy JF, et al. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry. 2010 May;167(5):580–588.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Nagai R. Islet inflammation in type 2 diabetes and physiology. J Clin Invest. 2017 Jan 3;127(1):14–23.
   PubMed Web of Science ®Google Scholar
• Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010 Dec;53(12):2480–2486.
   PubMed Web of Science ®Google Scholar
• Kan C, Silva N, Golden SH, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013 Feb;36(2):480–489.
   PubMed Web of Science ®Google Scholar
• Moulton CD, Costafreda SG, Horton P, et al. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav. 2015 Dec;9(4):651–662.
   PubMed Web of Science ®Google Scholar
• Ho N, Sommers MS, Lucki I. Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobehav Rev. 2013 Sep;37(8):1346–1362.
   PubMed Web of Science ®Google Scholar
• Rathmann W, Kuss O, Anderson D, et al. Increased depression symptom score in newly diagnosed type 2 diabetes patients. Psychiatry Res. 2018;261:259–263.
   PubMed Web of Science ®Google Scholar
• de Morais H, de Souza CP, Da Silva LM, et al. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: role of CB1 receptors. Eur Neuropsychopharmacol. 2016 Oct;26(10):1590–1600.
   PubMed Web of Science ®Google Scholar
• Da Silva Dias IC, Carabelli B, Ishii DK, et al. Indoleamine-2,3-Dioxygenase/Kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes. Mol Neurobiol. 2016 Dec;53(10):6997–7009.
   PubMed Web of Science ®Google Scholar
• Piazza FV, Segabinazi E, Centenaro LA, et al. Enriched environment induces beneficial effects on memory deficits and microglial activation in the hippocampus of type 1 diabetic rats. Metab Brain Dis. 2014 Mar;29(1):93–104.
   PubMed Web of Science ®Google Scholar
• Herder C, Hermanns N Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes. Seminars in immunopathology 2019 Feb 18.
   Google Scholar
• Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017 Mar;1391(1):20–34.
   PubMed Web of Science ®Google Scholar
• Gm K, Rm P, Zammit S, et al. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014 Oct;71(10):1121–1128.
   PubMed Web of Science ®Google Scholar
• Hayashino Y, Mashitani T, Tsujii S, et al. Elevated levels of hs-CRP are associated with high prevalence of depression in japanese patients with type 2 diabetes: the Diabetes Distress and Care Registry at Tenri (DDCRT 6). Diabetes Care. 2014 Sep;37(9):2459–2465.
   PubMed Web of Science ®Google Scholar
• Quek YH, Tam WWS, Zhang MWB, et al. Exploring the association between childhood and adolescent obesity and depression: a meta-analysis. Obes Rev. 2017 Jul;18(7):742–754.
   PubMed Web of Science ®Google Scholar
• Hiles SA, Lamers F, Milaneschi Y, et al. Sit, step, sweat: longitudinal associations between physical activity patterns, anxiety and depression. Psychol Med. 2017 Jun;47(8):1466–1477.
   PubMed Web of Science ®Google Scholar
• Cleal B, Panton UH, Willaing I, et al. Diabetes and depression in Denmark 1996-2010: national data stratified by occupational status and annual income. Diabet Med. 2017 Jan;34(1):108–114.
   PubMed Web of Science ®Google Scholar
• Stubbs B, Vancampfort D, Veronese N, et al. Depression and pain: primary data and meta-analysis among 237 952 people across 47 low- and middle-income countries. Psychol Med. 2017 Dec;47(16):2906–2917.
   PubMed Web of Science ®Google Scholar
• Bauer M, Severus E, Kohler S, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry. 2015 Feb;16(2):76–95.
   PubMed Web of Science ®Google Scholar
• Holt RI, de Groot M, Lucki I, et al. NIDDK international conference report on diabetes and depression: current understanding and future directions. Diabetes Care. 2014 Aug;37(8):2067–2077.
   PubMed Web of Science ®Google Scholar
• Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med. 2014 Jul;31(7):773–786.
   PubMed Web of Science ®Google Scholar
• Kivimaki M, Hamer M, Batty GD, et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care. 2010 Dec;33(12):2611–2616.
   PubMed Web of Science ®Google Scholar
• Burcu M, Zito JM, Safer DJ, et al. Association of Antidepressant Medications With Incident Type 2 diabetes among medicaid-insured youths. Jama Pediatr. 2017 Dec;171(12):1200–1207.
   PubMed Web of Science ®Google Scholar
• Kivimaki M, Batty GD, Jokela M, et al. Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association? Biol Psychiatry. 2011 Nov 15;70(10):978–984.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Zhou X, Del Giovane C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016 Aug 27;388(10047):881–890.
   PubMed Web of Science ®Google Scholar
• Hardy T, Sachson R, Shen S, et al. Does treatment with duloxetine for neuropathic pain impact glycemic control? Diabetes Care. 2007 Jan;30(1):21–26.
   PubMed Web of Science ®Google Scholar
• Deuschle M. Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry. 2013 Jan;26(1):60–65.
   PubMed Web of Science ®Google Scholar
• Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997 May-Jun;59(3):241–250.
   PubMed Web of Science ®Google Scholar
• Ibrahim FA, Rashid F, Hussain AA, et al. Rasagiline-induced severe recurrent hypoglycemia in a young woman without diabetes: a case report. J Med Case Rep. 2017 Feb 2;11(1):29.
   PubMedGoogle Scholar
• Himmerich H, Fulda S, Schaaf L, et al. Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care. 2006 Jan;29(1):170.
   PubMed Web of Science ®Google Scholar
• Echeverry D, Duran P, Bonds C, et al. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec;32(12):2156–2160.
   PubMed Web of Science ®Google Scholar
• Paile-Hyvarinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract. 2007 Jun 15;8:34.
   PubMed Web of Science ®Google Scholar
• Williams MM, Clouse RE, Nix BD, et al. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care. 2007 Apr;30(4):801–806.
   PubMed Web of Science ®Google Scholar
• Lustman PJ, Freedland KE, Griffith LS, et al. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000 May;23(5):618–623.
   PubMed Web of Science ®Google Scholar
• Paile-Hyvarinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract. 2003 May 14;4:7.
   PubMedGoogle Scholar
• Gulseren L, Gulseren S, Hekimsoy Z, et al. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res. 2005 Mar-Apr;36(2):159–165.
   PubMed Web of Science ®Google Scholar
• Petrak F, Herpertz S, Albus C, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the Diabetes and Depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care. 2015 May;38(5):767–775.
   PubMed Web of Science ®Google Scholar
• Khazaie H, Rahimi M, Tatari F, et al. Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? Neurosciences (Riyadh). 2011 Jan;16(1):42–45.
   PubMed Web of Science ®Google Scholar
• Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014;37(3):625–633.
   PubMed Web of Science ®Google Scholar
• Sahlen KG, Johansson H, Nystrom L, et al. Health coaching to promote healthier lifestyle among older people at moderate risk for cardiovascular diseases, diabetes and depression: a study protocol for a randomized controlled trial in Sweden. BMC Public Health. 2013 Mar;6(13):199.
   Google Scholar
• Ebert DD, Nobis S, Lehr D, et al. The 6-month effectiveness of Internet-based guided self-help for depression in adults with Type 1 and 2 diabetes mellitus. Diabet Med. 2017 Jan;34(1):99–107.
   PubMed Web of Science ®Google Scholar
• Xie J, Deng W. Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat. 2017;13:2681–2690.
   PubMed Web of Science ®Google Scholar
• Wang ZD, Xia YF, Zhao Y, et al. Cognitive behavioural therapy on improving the depression symptoms in patients with diabetes: a meta-analysis of randomized control trials. Biosci Rep. 2017 Apr 28;37:2.
   Web of Science ®Google Scholar
• Uchendu C, Blake H. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabet Med. 2017 Mar;34(3):328–339.
   PubMed Web of Science ®Google Scholar
• Li C, Xu D, Hu M, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res. 2017;95:44–54.
   PubMed Web of Science ®Google Scholar
• Chapman A, Liu S, Merkouris S, et al. Psychological Interventions for the management of glycemic and psychological outcomes of Type 2 diabetes Mellitus in China: a systematic review and meta-analyses of randomized controlled trials. Front Public Health. 2015;3:252.
   PubMedGoogle Scholar
• Wang MY, Tsai PS, Chou KR, et al. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J Clin Nurs. 2008 Oct;17(19):2524–2530.
   PubMed Web of Science ®Google Scholar
• Newby J, Robins L, Wilhelm K, et al. Web-based cognitive behavior therapy for depression in people with diabetes mellitus: a randomized controlled trial. J Med Internet Res. 2017 May 15;19(5):e157.
   PubMed Web of Science ®Google Scholar
• Nobis S, Lehr D, Ebert DD, et al. Efficacy of a web-based intervention with mobile phone support in treating depressive symptoms in adults with type 1 and type 2 diabetes: a randomized controlled trial. Diabetes Care. 2015 May;38(5):776–783.
   PubMed Web of Science ®Google Scholar
• Hermanns N, Schmitt A, Gahr A, et al. The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care. 2015 Apr;38(4):551–560.
   PubMed Web of Science ®Google Scholar
• Penckofer SM, Ferrans C, Mumby P, et al. A psychoeducational intervention (SWEEP) for depressed women with diabetes. Annals of behav med 2012 Oct;44(2):192–206.
   PubMed Web of Science ®Google Scholar
• van Bastelaar KM, Pouwer F, Cuijpers P, et al. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2011 Feb;34(2):320–325.
   PubMed Web of Science ®Google Scholar
• Piette JD, Richardson C, Himle J, et al. A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care. 2011 Jul;49(7):641–648.
   PubMed Web of Science ®Google Scholar
• Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998 Oct 15;129(8):613–621.
   PubMed Web of Science ®Google Scholar
• Atlantis E, Fahey P, Foster J. Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis. BMJ Open. 2014 Apr 12;4(4):e004706.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wei X, Wu T, et al. Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry. 2013 Oct;14(13):260.
   Google Scholar
• Johnson JA, Lier DA, Soprovich A, et al. Cost-effectiveness evaluation of collaborative care for diabetes and depression in primary care. Am J Prev Med. 2016 Jul;51(1):e13–e20.
   PubMed Web of Science ®Google Scholar
• Rauwerda NL, Tovote KA, Peeters A, et al. WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes. Diabet Med. 2018 Dec;35(12):1678–1685.
   PubMed Web of Science ®Google Scholar
• Janssen EP, Kohler S, Stehouwer CD, et al. The Patient Health Questionnaire-9 as a screening tool for depression in individuals with Type 2 diabetes mellitus: the Maastricht study. J Am Geriatr Soc. 2016 Nov;64(11):e201–e06.
   PubMed Web of Science ®Google Scholar
• Stahl D, Sum CF, Lum SS, et al. Screening for depressive symptoms: validation of the center for epidemiologic studies depression scale (CES-D) in a multiethnic group of patients with diabetes in Singapore. Diabetes Care. 2008 Jun;31(6):1118–1119.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB, et al. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345–359.
   PubMed Web of Science ®Google Scholar
• Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH, et al. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial. Diabetologia. 2011 Apr;54(4):741–748.
   PubMed Web of Science ®Google Scholar
• Ell K, Katon W, Xie B, et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care. 2010 Apr;33(4):706–713.
   PubMed Web of Science ®Google Scholar
• Hay JW, Katon WJ, Ell K, et al. Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes. Value Health. 2012 Mar-Apr;15(2):249–254.
   PubMed Web of Science ®Google Scholar